GeneDx Holdings (WGS) Gross Profit (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Gross Profit data on file, last reported at $68.2 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $68.2 million, up 16.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $307.9 million (up 42.91% YoY), and the FY2025 annual result was $298.2 million, up 53.38% from the prior year.
• Gross Profit retreated to $68.2 million in Q1 2026 per WGS's latest filing, from $84.3 million in the prior quarter.
• Over five years, Gross Profit peaked at $84.5 million in Q3 2025 and troughed at -$29.6 million in Q2 2022.
• A 5-year average of $36.7 million and a median of $37.4 million in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2023: Gross Profit slumped 2442.78% in 2022, then soared 288.37% in 2023.
• A 5-year view of Gross Profit shows it stood at -$16.3 million in 2022, then soared by 288.37% to $30.8 million in 2023, then jumped by 115.27% to $66.2 million in 2024, then grew by 27.28% to $84.3 million in 2025, then decreased by 19.05% to $68.2 million in 2026.
• Business Quant data shows WGS's Gross Profit at $68.2 million in Q1 2026, $84.3 million in Q4 2025, and $84.5 million in Q3 2025.